| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
Uridine 5-oxyacetic acid manufacturers
|
| | Uridine 5-oxyacetic acid Basic information |
| Product Name: | Uridine 5-oxyacetic acid | | Synonyms: | Uridine 5-oxyacetic acid;uridin-5-yloxyacetic acid;2-{3-[ACETYL(METHYL)AMINO]-2,4,6-TRIIODOPHENOXY}PROPANOIC ACID;2-((1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)oxy)acetic acid;RNA-modified nucleoside cmo5U;Acetic acid, 2-[(1,2,3,4-tetrahydro-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidinyl)oxy]- | | CAS: | 28144-25-4 | | MF: | C11H14N2O9 | | MW: | 318.24 | | EINECS: | | | Product Categories: | | | Mol File: | 28144-25-4.mol |  |
| | Uridine 5-oxyacetic acid Chemical Properties |
| density | 1.80±0.1 g/cm3(Predicted) | | pka | 2.88±0.10(Predicted) |
| | Uridine 5-oxyacetic acid Usage And Synthesis |
| Uses | Uridine-5-oxyacetic acid is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | Definition | ChEBI: Uridin-5-yloxyacetic acid is a derivative of uridine, bearing an additional carboxymethoxy substituent at position 5 on the uracil ring. It is a member of uridines and a monocarboxylic acid. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | Uridine 5-oxyacetic acid Preparation Products And Raw materials |
|